您的位置: 首页 > 农业专利 > 详情页

Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
专利权人:
Allergan; Inc.
发明人:
Jeffrey L. Edelman,Kelly M. Harrison
申请号:
US15043750
公开号:
US09820995B2
申请日:
2016.02.15
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes an Glucocorticoid Derivative which, upon delivery to the posterior segment of a mammalian eye, does not significantly diffuse to the anterior segment of said eye. Methods of making and using the present materials are also described.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充